Business
Perimeter Medical Imaging AI initiates new clinical trial site in Seattle, WA
(NewsDirect) Adrian Mendes, the CEO of Perimeter Medical Imaging, joined Steve Darling fr...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"Perimeter Medical Imaging AI initiates new clinical trial site in Seattle, WA\n \n \n (NewsDirect)\n \n \n \n \n Adrian Mendes, the CEO of Perimeter\nMedical Imaging, joined Steve Darling from Proactive with news that\nthe company has initiated an additional clinical trial site at the\nUniversity of Washington in the Fred Hutch Cancer Center.\n \n \n Perimeter's clinical trial is a\nmulti-center, randomized, two-arm pivotal study that evaluates the\ninvestigational Perimeter B-Series Optical Coherence Tomography (OCT)\ntechnology. This technology is combined with Perimeter's\nproprietary ImgAssist AI software and is used during breast\nconservation surgeries.\n \n \n The core of\nthis innovative approach is the use of ultra-high-resolution,\nreal-time, advanced imaging tools to examine excised tissues at the\ncellular level, providing crucial insights to surgeons.\n \n \n Mendes emphasized the significance of this\nadditional clinical trial site, as it plays a vital role in gathering\nvaluable data generated during the study. This data will be\ninstrumental in supporting the commercialization of Perimeter's\nB-Series technology.\n \n \n The\ncompany's ultimate goal is to transform cancer surgery by\nproviding advanced technology that not only improves patient outcomes\nbut also helps reduce healthcare costs.\n \n \n \n Contact\nDetails\n \n \n \n Proactive Investors\n \n \n +1 604-688-8158\n \n \n \n [email protected]\n \n \n \n Copyright (c) 2023 TheNewswire - All rights reserved.\n \n \n","length":1979,"tagName":"div"}]